Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...
Explore why Health Care may mean-revert in 2026. Compare XLV vs BME yields, valuation and NAV discount, plus key risks.
Ms Indranee was speaking on a motion expressing regret at Mr Singh’s conduct. Read more at straitstimes.com. Read more at ...
The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite.
24/7 Wall St. on MSN
Betting on More Rate Cuts, Boomers Are Buying the 2026 Small Dogs of the Dow
These five Dogs of the Dow may be the perfect play for 2026 for growth and income investors wary of volatility and a ...
Dow Jones Industrial Average, Chevron Corp, Coca-Cola Co, Merck & Company Inc. Read 's Market Analysis on Investing.com ...
An Ogun State customary court sitting in Ijebu Aiyepe has nullified the sale of portions of land belonging to the late Chief ...
Merck said on Monday it has raised its outlook for new growth drivers, forecasting $70 billion in revenue from these fresh ...
Merck (MRK) is back in focus after a trio of recent developments, including an upcoming J.P. Morgan Healthcare Conference ...
Healthcare dealmakers are heading to San Francisco this weekend betting on a new wave of mega-mergers in 2026 that could ...
Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all ...
We recently published 8 Stocks on Jim Cramer’s Radar. Merck & Co., Inc. (NYSE:MRK) is one of the stocks on Jim Cramer’s radars. Pharma giant Merck & Co., Inc. (NYSE:MRK)’s shares are up by 1.9% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback